FTC Delays Curium's $8 Billion Lantheus Acquisition

The Federal Trade Commission has delayed the proposed $8 billion acquisition of Lantheus Holdings Inc. by Curium. The agency issued a request for additional information regarding the transaction, which involves two major players in the radiopharmaceutical industry.

This regulatory action has extended the mandatory waiting period for the merger. As a result, the transaction cannot close while the agency conducts its detailed review of the deal's potential impact on the market.